Azza A K El-Sheikh

19PUBLICATIONS
25CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Traditional, complementary and integrative medicine not elsewhere classifiedPredictive and prognostic markersScience, technology and engineering curriculum and pedagogyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 28, 2025
Effect of Pharmacogenetics on Renal Outcomes of Heart Failure Patients with Reduced Ejection Fraction (HFrEF) in Response to Dapagliflozin.

Neven Sarhan, Mona F Schaalan, Azza A K El-Sheikh

|Jan 23, 2024
Correction: Mohammed et al. Assessment of Knowledge, Attitude, and Practice towards Tuberculosis among Taif University Students. Healthcare 2023, 11, 2807.

Eilaf A Mohammed, Huriyyah A Alotaibi, Joud F Alnemari

|Nov 25, 2023
Targeting Autophagy, Apoptosis, and Oxidative Perturbations with Dapagliflozin Mitigates Cadmium-Induced Cognitive Dysfunction in Rats.

Hany H Arab, Ahmed H Eid, Shuruq E Alsufyani

|Oct 28, 2023
Assessment of Knowledge, Attitude, and Practice towards Tuberculosis among Taif University Students.

Eilaf A Mohammed, Huriyyah A Alotaibi, Joud F Alnemari

|Sep 28, 2023
Targeting Autophagy, Apoptosis, and SIRT1/Nrf2 Axis with Topiramate Underlies Its Neuroprotective Effect against Cadmium-Evoked Cognitive Deficits in Rats.

Hany H Arab, Ahmed H Eid, Rania Yahia

|Aug 26, 2023
Neuroprotective Impact of Linagliptin against Cadmium-Induced Cognitive Impairment and Neuropathological Aberrations: Targeting SIRT1/Nrf2 Axis, Apoptosis, and Autophagy.

Hany H Arab, Ahmed H Eid, Shuruq E Alsufyani

Pageof 4

Frequent Collaborators

9 joint publications

Hany H Arab

7 joint publications

Shuruq E Alsufyani

6 joint publications

Ahmed M Ashour

2 joint publications

Mohamed A Morsy